Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-963-1 | CAS number: 90-04-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Mutagenic activity of o-anisidine was investigated in a reliable bacterial reverse mutation assay similar to guidelines which was selected as key study. This study was performed using Salmonella typhimurium strains TA1535, TA1537, TA98, TA100 and TA1538 as well as Escherichia coli WP2 uvrA with and without metabolic activation (induced rat liver S9-mix) at concentrations of 0.004, 0.02, 0.1, 0.5, 2.5 and 10 µl/plate. Under the conditions tested the test compound was not mutagenic because no significant increase in the number of revertant colonies and no dose dependent effects were observed.
A variety of studies described in the EU-Risk Assessment Report gave negative as well as positive results for o-anisidine genotoxicity in vitro and in vivo:
Negative as well as positive or ambiguous results were observed in bacterial reverse mutation assays under different conditions.
No unscheduled DNA synthesis could be observed in rat hepatocytes and only weak positive results were shown in an alkaline elution assay. Positive test results were obtained in a sister chromatide assay and two chromosome aberration assays, as well as in a mouse lymphoma assay (with or without metabolic activation).
o- Anisidine was tested in several in vivo micronucleus assays. In one assay the test compound was administered orally by gavage to male and female mice. The animals were treated once with 1000 mg/kg bw (including vehicle and positive control) and according to the test procedure the animals were killed 24, 48 or 72 hours after application. No induction of micronuclei was observed under these test conditions, but systemic toxicity was already detectable. Negative results were also obtained in several other in vivo micronucleus assays. Additionally, no formation of DNA-adducts, no DNA-single strand break and UDS were detectable in vivo. Negative results were also obtained in a sex linked recessive lethal assay.
Positive results in vivo were obtained in a host mediated assay, somatic mutation and recombination assay in Drosophila melanogaster and a transgenic mouse mutation assay (Big Blue Mouse TM), furthermore, inhibition of testicular DNA-synthesis was observed in male mice.
Short description of key information:
In a variety of reverse bacterial mutation assays the test material showed negative as well as positive results in the presence and absence of metabolic activation. Mutagenic effects in vitro were reported for chromosome aberration tests and mouse lymphoma assays with and without metabolic activation. Tests for unscheduled DNA-synthesis in vitro were consistently negative. In vivo assays gave mostly negative results (e.g. micronucleus assay in vivo), but also some positive results were obtained (e.g. transgenic mouse mutation assay).
Endpoint Conclusion: Adverse effect observed (positive)
Justification for classification or non-classification
In accordance with the evaluation in the EU-RAR it is concluded that there is sufficient evidence that o-anisidine is genotoxic. There are contradictory results in in vitro short-term tests as well as in in vivo assays. The evidence from the transgenic mouse mutation assay and supporting in vitro and in vivo evidence is considered to be sufficient for classification as Muta 2, H341 or Muta. Cat. 3; R68, which fits to current classification in Annex VI to Regulation (EC) No.1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.